NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NovoBind Livestock Therapeutics Inc.

NovoBind Livestock Therapeutics Inc.

Private
Vancouver, British ColumbiaHealthcare & Life Scienceshttps://www.novobind.com/

Last Round

Grant

Nov 1, 2021

Total Funding Raised

$1.08M

Company Overview

NovoBind Livestock Therapeutics Inc. is a biotechnology company that develops next-generation biologics to neutralize bacteria, viruses, and parasites that cause intestinal ailments in livestock, aquaculture, and pets.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

feed additivesnanobodiesantibiotic alternativesanimal healthsingle-domain antibodiesVHHslivestock therapeuticspoultry healthbiologics platformagritechanimal biotechnologynecrotic enteritisAGP-free solutionscamelid antibodies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NovoBind Livestock Therapeutics Inc. Comparables

Compare NovoBind Livestock Therapeutics Inc. with similar companies based on industry and business-model similarity.

NovoBind Livestock Therapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

NovoBind Livestock Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2021
GrantSep 1, 2020
Series AFeb 19, 2020
GrantJul 1, 2019

Key People

Founding team and executive leadership

CPA CA Hamlet Abnousi

Co-Founder And CEO

Founding Team

NovoBind Livestock Therapeutics Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2021

    $486K grant received from Agriculture and Agri-Food Canada.

  • Sep 1, 2020

    $530K grant received from Agriculture and Agri-Food Canada.

NovoBind Livestock Therapeutics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NovoBind Livestock Therapeutics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NovoBind Livestock Therapeutics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver, British Columbia
Employee Range6
Year Founded2012
Last FundingNov 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.